Milestone Scientific Overview
Valuation check: MLSS's PEG ratio is 35.28, above the Healthcare sector average of 2.89.
Get informed when a big investor buys or sells
+ Follow35.28
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
Milestone Scientific's peg ratio stands at 35.28. That is above the Healthcare sector average of 2.89. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Milestone Scientific sits higher the Healthcare benchmark (2.89) with a PEG ratio of 35.28. That is roughly 1120.3% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
Whether 35.28 is attractive depends on Milestone Scientific's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.
The history chart shows how Milestone Scientific's PEG ratio evolved across reporting periods, while the comparison chart places MLSS next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
Yes — within Healthcare, PEG ratio is commonly used to spot outliers. Milestone Scientific's reading of 35.28 (sector avg 2.89) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.
